{
  "citations" : [],
  "guideline" : {
    "objCls" : "Guideline Annotation",
    "id" : "PA166182845",
    "name" : "Annotation of DPWG Guideline for fluvastatin and SLCO1B1",
    "alternateDrugAvailable" : false,
    "cancerGenome" : false,
    "crossReferences" : [],
    "dosingInformation" : false,
    "hasTestingInfo" : false,
    "history" : [
      {
        "id" : 1450415250,
        "date" : "2019-05-27T00:00:00-07:00",
        "description" : "Annotation current with November 2018 DPWG Guideline release",
        "type" : "Create",
        "version" : 0
      },
      {
        "id" : 1450820650,
        "date" : "2019-10-03T14:02:27.606-07:00",
        "description" : "No changes based on August 2019 guideline",
        "type" : "Note",
        "version" : 0
      },
      {
        "id" : 1450963503,
        "date" : "2020-02-11T05:55:06.690-08:00",
        "description" : "Fixed links to 2018 guideline pdfs.",
        "type" : "Update",
        "version" : 0
      },
      {
        "id" : 1451257920,
        "date" : "2020-08-31T17:47:06.021-07:00",
        "description" : "updated to reflect wording in August 2020 update",
        "type" : "Update",
        "version" : 0
      },
      {
        "id" : 1451704182,
        "date" : "2022-03-03T16:33:22.962-08:00",
        "description" : "Annotation current with May 2021 DPWG Guideline release",
        "type" : "Note",
        "version" : 0
      },
      {
        "id" : 1451732822,
        "date" : "2022-03-28T09:57:36.617-07:00",
        "description" : "Annotation current with February 2022 DPWG guideline release",
        "type" : "Note",
        "version" : 0
      },
      {
        "id" : 1451884268,
        "date" : "2022-09-16T10:18:02.629-07:00",
        "description" : "Fixed link to gene information document and added explanatory note",
        "type" : "Update",
        "version" : 0
      },
      {
        "id" : 1452146446,
        "date" : "2023-07-03T13:39:46.438-07:00",
        "description" : "Annotation current with May 2023 DPWG Guideline release",
        "type" : "Note",
        "version" : 0
      },
      {
        "id" : 1452411600,
        "date" : "2024-03-18T11:17:49.766-07:00",
        "description" : "Updated links for risk analysis pdf.",
        "type" : "Update",
        "version" : 0
      },
      {
        "id" : 1452424583,
        "date" : "2024-03-29T11:42:32.061-07:00",
        "description" : "Removed message about gene information document availability.",
        "type" : "Update",
        "version" : 0
      }
    ],
    "literature" : [
      {"id":15103288,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2019","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","crossReferences":[{"id":1450815695,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf"}],"objCls":"Literature","terms":[],"type":"Literature"},
      {"id":15113882,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2020","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2020.pdf","crossReferences":[{"id":1451257580,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2020.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2020.pdf"}],"objCls":"Literature","terms":[],"type":"Literature"},
      {"id":15102465,"title":"Dutch Pharmacogenetics Working Group Guidelines November 2018","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","crossReferences":[{"id":1450415575,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf"}],"objCls":"Literature","terms":[],"type":"Literature"}
    ],
    "otherPrescribingGuidance" : false,
    "pediatric" : false,
    "recommendation" : false,
    "relatedAlleles" : [
      {
        "objCls" : "Variant",
        "id" : "PA166154579",
        "symbol" : "rs4149056",
        "name" : "rs4149056",
        "version" : 6
      }
    ],
    "relatedChemicals" : [
      {
        "objCls" : "Chemical",
        "id" : "PA449688",
        "name" : "fluvastatin",
        "version" : 22
      }
    ],
    "relatedGenes" : [
      {
        "objCls" : "Gene",
        "id" : "PA134865839",
        "symbol" : "SLCO1B1",
        "name" : "solute carrier organic anion transporter family member 1B1",
        "version" : 49
      }
    ],
    "source" : "DPWG",
    "summaryMarkdown" : {
      "id" : 1450415248,
      "html" : "<p>There are currently no recommendations for fluvastatin dosing based on SLCO1B1 genotypes.</p>\n",
      "version" : 0
    },
    "terms" : [],
    "textMarkdown" : {
      "id" : 1450415249,
      "html" : "<h3 id=\"august-2020-guideline-update\">August 2020 Guideline update</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG) has evaluated therapeutic dose recommendations for fluvastatin based on SLCO1B1 genotypes. They conclude for <em>SLCO1B1</em> 521TC or 521CC and fluvastatine that no action is required for this gene-drug interaction. The gene variation increases the plasma concentration of fluvastatin, but there is insufficient evidence to prove an effect on efficacy or side effects. (See the <a download=\"DPWG_August_2020.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_August_2020.pdf\">Dutch guidelines August 2020 update</a>)</p>\n<p><a download=\"DPWG_SLCO1B1_fluvastatin_4059-4060.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_SLCO1B1_fluvastatin_4059-4060.pdf\">Read for more information about this recommendation</a>, <a download=\"SLCO1B1.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/SLCO1B1.pdf\">Read about gene information from DPWG</a></p>\n<h3 id=\"november-2018-guideline\">November 2018 Guideline</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG) has evaluated therapeutic dose recommendations for fluvastatin based on SLCO1B1 genotypes. They conclude that no action is needed for this gene-drug interaction. (See the <a download=\"DPWG_November_2018.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_November_2018.pdf\">Dutch guidelines November 2018 update</a>)</p>\n",
      "version" : 6
    },
    "version" : 11
  }
}